◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksI › ICLR

ICON PLC (ICLR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DIAGNOSTICS & RESEARCH · DATA UPDATED 2026-09-19

ICON PLC (ICLR) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Dublin, Ireland with about 40,200 employees. Its market capitalization is roughly $13 billion. In the fiscal year ended 2025-12-31, ICLR reported $8.3B in revenue and $229M in net income.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Interactive charts & full statements → Open the ICLR valuation workbench →

ICLR Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$8.3B$8.3B$8.3B$8.1B$7.7B$5.5B$2.8B$2.8B$2.6B$1.8B$1.7B$1.6B$1.5B$1.3B$1.1B$946M$900M$888M$865M$631M$456M
Gross Profit$1.9B$2.2B$2.4B$2.4B$2.2B$1.5B$808M$832M$769M$727M$705M$666M$600M$491M$397M$334M$359M$380M$376M$276M$199M
Gross Margin %23.0%26.4%29.4%29.6%28.6%27.5%28.9%29.6%29.6%41.3%42.3%42.3%39.9%36.7%35.6%35.3%39.9%42.8%43.5%43.8%43.8%
Operating Income (EBIT)$857M$1.0B$1.1B$956M$795M$379M$392M$433M$373M$338M$312M$282M$202M$121M$72M$39M$92M$107M$100M$69M$48M
Operating Margin %10.3%12.3%13.3%11.8%10.3%6.9%14.0%15.4%14.4%19.2%18.7%17.9%13.5%9.1%6.5%4.2%10.2%12.1%11.5%11.0%10.5%
Net Income$70M$229M$791M$612M$505M$153M$328M$374M$323M$281M$262M$240M$172M$103M$55M$23M$87M$94M$78M$56M$38M
Net Margin %0.8%2.8%9.6%7.5%6.5%2.8%11.7%13.3%12.4%16.0%15.7%15.2%11.5%7.7%5.0%2.4%9.7%10.6%9.0%8.9%8.4%
EBITDA$824M$1.6B$1.5B$1.4B$739M$489M$532M$452M$402M$379M$339M$264M$169M$111M$69M$128M$141M$130M$88M$63M
Earnings Per Share (EPS)$0.89$2.90$9.53$7.40$6.13$2.25$6.15$6.88$5.90$5.13$4.65$3.97$2.73$1.65$0.91$0.37$1.44$1.57$1.30$1.88$1.33
Shares Outstanding (M)79M83M83M82M68M53M54M55M55M56M60M63M62M61M61M61M60M60M30M29M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICLR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$2.1B$2.0B$2.2B$2.0B$2.0B$2.0B$2.0B$2.0B$2.1B
Gross Profit$479M$478M$501M$456M$562M$559M$599M$591M$627M
Gross Margin %23.2%23.5%22.9%22.3%27.8%27.9%29.4%29.1%29.5%
Operating Income (EBIT)$194M$174M$230M$259M$209M$220M$297M$285M$230M
Operating Margin %9.4%8.5%10.5%12.7%10.4%11.0%14.5%14.1%10.8%
Net Income$73M$105M($110M)$2M$183M$154M$260M$197M$147M
Net Margin %3.5%5.1%-5.0%0.1%9.1%7.7%12.7%9.7%6.9%
EBITDA$277M$187M$309M$317M$366M$381M$381M
Earnings Per Share (EPS)$0.94$1.36$-1.44$0.03$2.30$1.87$3.16$2.36$1.76
Shares Outstanding (M)77M77M78M80M82M82M83M83M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICLR Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$1.1B$1.0B$1.3B$1.2B$563M$829M$595M$413M$264M$383M$259M$280M$170M$221M$114M$20M$87M$255M$81M$43M$50M
Capital Expenditures (CapEx)$189M$174M$168M$141M$142M$94M$51M$51M$48M$0M$43M$50M$33M$29M$31M$35M$31M$34M$68M$75M$32M
Free Cash Flow (FCF)$902M$862M$1.1B$1.0B$421M$735M$544M$362M$216M$383M$217M$230M$137M$192M$83M($15M)$56M$221M$13M($32M)$19M
FCF Margin %10.8%10.4%13.5%12.6%5.4%13.4%19.4%12.9%8.3%21.8%13.0%14.6%9.1%14.3%7.4%-1.6%6.3%24.9%1.6%-5.1%4.2%
Dividends Paid$36M$13M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICLR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$281M$167M$234M$409M$162M$268M$338M$403M$219M
Capital Expenditures (CapEx)$42M$31M$59M$57M$35M$29M$61M$43M$36M
Free Cash Flow (FCF)$239M$136M$175M$352M$128M$239M$277M$359M$183M
FCF Margin %11.6%6.7%8.0%17.2%6.3%12.0%13.6%17.7%8.6%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICLR Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$16.4B$16.3B$16.9B$17.0B$17.2B$17.4B$3.4B$2.9B$2.4B$2.2B$1.8B$1.7B$1.5B$1.4B$1.2B$1.0B$950M$908M$867M$693M$476M
Cash & Cash Equivalents$928M$647M$539M$378M$289M$752M$840M$520M$396M$283M$193M$104M$119M$183M$114M$119M$256M$145M$58M$77M$63M
Total Liabilities$7.0B$7.1B$7.4B$7.7B$8.7B$9.3B$1.6B$1.3B$1.0B$956M$881M$955M$578M$532M$448M$354M$280M$336M$411M$303M$172M
Total Debt (Short + Long-Term)$3.5B$3.4B$3.5B$3.8B$4.7B$5.5B$373M$378M$684M$606M$548M$587M$602M$544M$189M$0M$0M$0M$106M$95M$5M
Total Shareholders' Equity$9.4B$9.2B$9.5B$9.2B$8.5B$8.1B$1.9B$1.6B$1.4B$1.2B$945M$764M$950M$911M$755M$682M$670M$572M$456M$388M$303M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ICLR viewer.

ICLR Metric Deep Dives

Other Companies in DIAGNOSTICS & RESEARCH

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← ICLPAll “I” companiesICLX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.